Free symposium: Malaria in Pregnancy
Tags:
Date: Friday 24 April 2015
Time: 8 a.m.- 5 p.m.
Location: Johns Hopkins University, Mountcastle Auditorium, 725 N. Wolfe Street, Baltimore, Maryland, USA
Registration deadline: 31 March 2015
MalariaWorld Events's blog
The 5th International Conference of Plasmodium vivax Research
Date: 19-22 May 2015Location: Intercontinental Bali, Jimbaran, Bali, Indonesia
Abstract submission deadline: 26 January 2015
EMBL Conference: BioMalPar XI: Biology and Pathology of the Malaria Parasite
Date: 11 - 13 May 2015Location: EMBL Heidelberg, Germany
Abstract deadline: 9 March 2015
Registration deadline: 16 April 2015
Registration deadline: 16 April 2015
Registration is now open! Please visit the registration page.
Press release Vestergaard: World Health Organization's Vector Control Advisory Group supports Permanet® 3.0 Long-Lasting insecticidal bed net
Tags:
Switzerland, October 27 -- The World Health Organization’s (WHO’s) Vector Control Advisory Group (VCAG) published its second annual VCAG report today which includes evaluation of the supporting evidence for Vestergaard’s product claim for PermaNet® 3.0. The report states that “The manufacturers have been very careful to make a relatively modest claim that can be supported by the combined evidence from multiple studies in many areas of pyrethroid resistance”.Publish your next manuscript in the MalariaWorld Journal
MalariaWorld Journal (MWJ) is the first truly Open Access, peer reviewed, journal with an exclusive focus on malaria –
MESA launches new website and knowledge management tools
Tags:
MESA is very excited to be launching its new website and knowledge management tools at ASTMH in New Orleans on November 2nd!
MMV Announces Call for Applications for Malaria Box Challenge Grants
Grants will support researchers in following up on Malaria Box open source data, available on ChEMBL.
Correction GMAP2
Tags:
The draft GMAP2 will be be available for you to read and feedback on later this year - but not on Oct 15th 2014.
The GMAP2 online consultation will be be launched later this year
Tags:
The Second Global Malaria Action Plan (GMAP2) will cover the timeframe 2016-2025.
You are strongly encouraged to have a look and contribute by sharing your vision for a malaria-free world.
Webinar 'Evaluating antimalarial safety' from ACT consortium, Oct 7th 2014
Tags:
Clinical trials are not suitable to identify rare, potentially serious adverse effects of drugs, or to define their safety in high risk populations.
Artemisinin-based combination therapies (or ACTs) are considered safe, but there are concerns over their potential to cause damage to parts of the brain. There is also a concern about their safety in patients infected with HIV.
Pages
